Drug application
NAPHCON-A (NAPHAZOLINE HYDROCHLORIDE, PHENIRAMINE MALEATE)
Drugs@FDA NDA 020226 · ALCON
Key facts
| Drug name | NAPHCON-A |
|---|---|
| Active ingredients | NAPHAZOLINE HYDROCHLORIDE, PHENIRAMINE MALEATE |
| Application type | NDA |
| Application number | 020226 |
| Company | ALCON |
| Dosage forms | SOLUTION/DROPS, OPHTHALMIC |
| Strength | 0.025%;0.3% |
| Marketing status | Over-the-counter |
| Reference listed drug | Yes |
| Latest submission class | Type 4 - New Combination |
| Latest submission status date | Jun 8, 1994 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- 1–9 Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: